SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-054980
Filing Date
2020-05-01
Accepted
2020-05-01 08:10:20
Documents
5
Period of Report
2020-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2018335-1_8k.htm 8-K 23069
2 EXHIBIT 99.1 tm2018335d1_ex99-1.htm EX-99.1 46012
3 EXHIBIT 99.2 tm2018335d1_ex99-2.htm EX-99.2 10336
4 GRAPHIC tm2018335d1_ex99-1img001.jpg GRAPHIC 12247
5 GRAPHIC tm2018335d1_ex99-2img001.jpg GRAPHIC 12247
  Complete submission text file 0001104659-20-054980.txt   114821
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 20838411
SIC: 2836 Biological Products, (No Diagnostic Substances)